This article was translated by John R. Bopp
It’s been a while since we’ve blogged about Parkinson’s, and, we admit, it’s been a while since we blogged about Basque research.
So today we’re bringing you an article from the News Medical website written by Sally Robertson, as it seemed especially important to us. It’s about an experimental study being carried out by researchers at the Basque public university, working on a study that could have potentially beneficial results with two proteins in patients with this disease.
The encouraging results of this research indicate that the use of these proteins in the fight against Parkinson’s will not only slow the progression of the disease, but perhaps even reduce it.
We can’t forget that this is just research and that, even if these results are confirmed, it will be a long road to converting this into a treatment for humans.
News Medical -15/1/2018 – Gran Bretaña
Administration of Two Proteins Shown to Counteract Neurodegeneration in Parkinson’s Disease
A combination therapy made up of two neurotrophic factors has been shown to reduce the degenerative effects of Parkinson’s disease, report researchers from the UPV/EHU-University of the Basque Country. The two factors; Vascular Endothelial Growth Factor (VEGF) and Glial Cell-derived Neurotrophic Factor (GDNF), are proteins that play an essential role in nerve cell function by inducing cell growth, plasticity and survival.